期刊文献+

羟考酮缓释片联合普瑞巴林治疗中重度非癌性神经病理性疼痛临床观察 被引量:15

下载PDF
导出
摘要 神经病理性疼痛是指机体受到损害或疾病累及躯体感觉神经系统后出现的疼痛。主要的临床表现为麻痛、针刺样疼痛、电击样疼痛、刀割样疼痛、放电样疼痛等。神经病理性疼痛是一种难治的疾病。据不完全统计,约有7%~8%的人一生中经历过神经病理性疼痛的困扰。神经病理性疼痛主要包括带状疱疹后神经痛、糖尿病周围神经病变、慢性腰痛、三叉神经痛、慢性胰腺炎累计神经等多种疾病。
出处 《中国疼痛医学杂志》 CAS CSCD 2016年第5期389-392,共4页 Chinese Journal of Pain Medicine
  • 相关文献

参考文献18

  • 1Bouhassira D,Lanteri-Minet M,Attal N,et al.Prevalence of chronic pain with neuropathic characteristics in general population.Pain,2008,136(3):380-387.
  • 2Garciadeparedes M,Del Moraldel Moral Gonzalezf,Ma Rtinez Delpradop,et al.First evidence of oncologic neuropathic pain prevalence after screening 8615cancer patients.results of the on study.Ann Oncol,2011,22(4):924-930.
  • 3Rainer F,Michael S,Birol E,et al.A Comprehensive Drug Safety Evaluation of Pregabalin in Peripheral Neuropathic Pain.Pain Practice,2015,15,(1):47-57.
  • 4廖兴志,熊源长.神经性疼痛机制在慢性胰腺炎中的作用[J].世界华人消化杂志,2009,17(31):3229-3232. 被引量:3
  • 5Gatti A,Casali M,Lazzari M,et al.Prolonged Release Oxycodone/Naloxone in Nonmalignant Pain:SingleCenter Study in Patients with Constipation.Adv Ther,2013,30(1):41-59.
  • 6Cloutier C,Taliano J,O'Mahony W,et al.Controlledreleaseoxycodone and naloxone in the treatment of chronic low back pain:a placebo-controlled,randomized study.Pain Res Manag,2013,18(2):75-82.
  • 7Hermanns K,Junker U,Nolte T.Prolonged-release oxycodone/naloxone in the treatment of neuropathic painresults from a large observational study.Expert Opin Pharmacother,2012,13(3):299-311.
  • 8李招胜,林洪,沙漠,丁真奇.神经病理性疼痛的药物治疗研究进展[J].中国临床药理学与治疗学,2013,18(9):1076-1080. 被引量:23
  • 9赵志奇.带状疱疹痛:基础和临床概述[J].中国疼痛医学杂志,2014,20(6):369-375. 被引量:68
  • 10郭歆,刘晓磊,程航,曹亚杰,曹伟,龚倩,李筱旻,程泽能.普瑞巴林胶囊的人体药动学研究[J].中国药学杂志,2009,44(5):362-366. 被引量:8

二级参考文献185

  • 1宁光,邹大进,刘伟,刑惠莉,张炜,赵咏桔,鲁瑾,徐华,金杰.神经妥乐平治疗糖尿病神经病变的多中心研究[J].中华医学杂志,2004,84(21):1785-1787. 被引量:39
  • 2赵华 ,温海鹰 ,王喜钟 ,李恒进 .神经妥乐平治疗带状疱疹后遗神经痛的临床研究[J].中国疼痛医学杂志,2005,11(3):165-166. 被引量:13
  • 3王韵.带状疱疹痛与带状疱疹后神经痛[J].中国疼痛医学杂志,1996,2(4):237-241. 被引量:25
  • 4LAURIA HORNER B A, POHLI R B. Pregabalin: a new anxiolytic [J]. Expert Opin Investig Drugs, 2003, 12(4): 663-672.
  • 5OWEN R T. Pregabalin: its efficacy, safety and tolerability profile in generalized anxiety [J]. Drugs Today, 2007, 43(9): 601-610.
  • 6SHNEKER B F, MCAULEY J W. Pregabalin: a new neuromodulator with broad therapeutic indications [J]. Ann Pharmacother, 2005, 39(12): 2029-2037.
  • 7GUAY D R. Pregabalin in neuropathic pain "pharmaceutically elegant" gabapentin[J]. Am J Geriatr Pharmaeother, 2005, 3(4): 274-287.
  • 8JOHANNESSEN S I, TOMSON T. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed [J]. Clin Pharmacokinet, 2006, 45(11): 1061-1075.
  • 9PERUCCA E. Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age [J]. Clin Pharmacokinet, 2006, 45(4): 351-363.
  • 10BIALER M. The pharmacokinetics and interactions of new antiepileptic drugs: an overview [J]. Ther Drug Monit, 2005, 27(6): 722-726.

共引文献402

同被引文献113

引证文献15

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部